Methods and devices for tissue treatment
AssigneeBTL Medical Technologies S.R.O.
InventorsTomá{hacek over (s)} Schwarz, Daniel Mali{hacek over (s)}
Life of this patent
Estimating the term…
Abstract
The presented methods and devices may provide at least one treatment action leading to one or more treatment effects including influencing the tissue to enhance, renew or improve biosynthesis of at least one component of an extracellular matrix. In one embodiment, the methods and devices may provide treatment effects to skin fibroblasts and/or fasciacytes of the patient, influencing the skin fibroblasts and/or fasciacytes to enhance, renew or improve biosynthesis of hyaluronic acid.
Claims22
A method for enhancement, renewing or improvement of biosynthesis of hyaluronic acid in a skin of a patient comprising:
- positioning at least one applicator in contact with the skin of the patient;
- providing a first type of energy via at least one radiofrequency electrode driven by a central control unit, providing a heating having an energy flux on the surface of the skin in a range of 0.001 W/cm2 to 1500 W/cm2 and an output power of less than or equal to 250 W, wherein the radiofrequency electrode is a dielectric electrode coated with insulating material and having a surface area in a range of 0.01 cm2 to 250 cm2;
- providing a second type of energy providing a targeted heating and having an energy flux on the surface of the skin in a range of 0.001 W/cm2 to 250 W/cm2 and an output power of less than or equal to 20 W;
- applying the first and second types of energy to a reticular dermis and/or an epidermal basal layer;
- heating the reticular dermis and/or the epidermal basal layer to a temperature in a range of 35° C. to 65° C.;
- and
- stimulating the skin to enhance, renew or improve biosynthesis of hyaluronic acid;
- and
- obtaining a temperature of one or more energy delivering elements from a temperature sensor located in the applicator.
A method for enhancement, renewing or improvement of biosynthesis of hyaluronic acid in a skin of a patient comprising:
- providing a first type energy providing a non-targeted vibrational movement of at least one cell and having an energy flux on the surface of the skin in a range of 0.001 W/cm2 to 1500 W/cm2 and an output power less than or equal to 250 W;
- providing a second type of energy providing a heating having an energy flux on the surface of the skin in a range of 0.001 W/cm2 to 250 W/cm2 and an output power less than or equal to 20 W;
- wherein the first and second types of energy are applied to reticular dermis and/or epidermal basal layer;
- and
- heating the reticular dermis and/or the epidermal basal layer to a temperature in a range of 35° C. to 65° C.;
- wherein both types of energies are provided from a replaceable tip of an applicator in contact with the skin of the patient, the replaceable tip including at least one of a radiofrequency electrode, ultrasound energy generator, acoustic window, or sensor;
- and
- stimulating the skin to enhance, renew or improve biosynthesis of hyaluronic acid.
A method for enhancement, renewing or improvement of biosynthesis of hyaluronic acid in a skin of a patient comprising:
- positioning at least one applicator in contact with the skin of the patient;
- providing a radiofrequency energy via at least one radiofrequency electrode driven by a central control unit, which is providing a treatment action and having a frequency in a range of 350 kHz to 100 MHz, output power on the surface of the skin less than or equal to 250 W, energy flux in a range of 0.001 W/cm2 to 1500 W/cm2, and surface area of the electrode in a range of 0.01 cm2 to 250 cm2, wherein the radiofrequency electrode is a dielectric electrode coated with insulating material;
- providing a second type of energy providing a targeted treatment action;
- wherein both treatment actions are applied to a reticular dermis and/or an epidermal basal layer;
- and
- heating the reticular dermis and/or the epidermal basal layer to a temperature in a range of 35° C. to 65° C.;
- stimulating the skin to enhance, renew or improve biosynthesis of hyaluronic acid;
- wherein both treatment actions cause proliferation of fibroblasts;
- and
- wherein the applicator includes an applicator user interface configured to inform the user about at least one therapy parameter.
Dependencies are inferred from the claim text.